About Us
Services
Hearing Aids
Patient Resources
Tinnitus is a complex condition that affects 10 - 15% of the population. Tinnitus involves hearing, attention and emotion centers in the brain. Lenire uses bimodal neuromodulation to treat tinnitus, a combination of tongue and hearing stimulation. This paired stimulation retrains the brain to reduce the severity of tinnitus.
Lenire, is the first non-invasive bimodal neuromodulation device shown to soothe and relieve tinnitus in a controlled large-scale clinical trial. As a result, Lenire is the first treatment device of its kind to be granted De Novo FDA approval.